| Frederick S Kelsey, MD | |
|
101 Boulder Point Dr, Suite 1, Plymouth, NH 03264 | |
| (603) 536-4000 | |
| (603) 536-4001 |
| Full Name | Frederick S Kelsey |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Location | 101 Boulder Point Dr, Plymouth, New Hampshire |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1518908151 | NPI | - | NPPES |
| RE4060 | Other | NH | MEDICARE GROUP |
| 30001184 | Medicaid | NH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 6088 (New Hampshire) | Primary |
| Entity Name | Mid-state Health Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235170549 PECOS PAC ID: 1951363563 Enrollment ID: O20041027000215 |
News Archive
New research from psychologists and health professionals in Swansea has found that the types of life values that patients hold affect their attendance at medical treatment for pelvic-floor dysfunction, a condition affecting over 25% of all women in the UK.
A study of how one protein enzyme, BubR1, helps make sure chromosomes are equally distributed during mitosis might explain how the process of cell division goes so awry in cancer, according to researchers from Fox Chase Cancer Center.
The Substance Abuse and Mental Health Services Administration (SAMHSA) announced a new application process for its major block grant programs - the Substance Abuse Prevention and Treatment Block Grant and the Community Mental Health Services Block Grant. The change is designed to provide states greater flexibility to allocate resources for substance abuse and mental illness prevention, treatment and recovery services in their communities.
Agendia, Inc., a world leader in personalized medicine and molecular cancer diagnostics, announces the peer-reviewed publication of the primary outcome results of the Microarray In Node-negative and 1 to 3 positive lymph node Disease may Avoid ChemoTherapy (MINDACT) clinical trial in the prestigious New England Journal of Medicine (NEJM). (i, iii, iv) The publication demonstrates that 46% of breast cancer patients considered for chemotherapy, whose tumors are classified MammaPrint Low Risk, have excellent survival without chemotherapy, and can thus be candidates to avoid this toxic therapy.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Frederick S Kelsey, MD 101 Boulder Point Dr, Suite 1, Plymouth, NH 03264 Ph: (603) 536-4000 | Frederick S Kelsey, MD 101 Boulder Point Dr, Suite 1, Plymouth, NH 03264 Ph: (603) 536-4000 |
News Archive
New research from psychologists and health professionals in Swansea has found that the types of life values that patients hold affect their attendance at medical treatment for pelvic-floor dysfunction, a condition affecting over 25% of all women in the UK.
A study of how one protein enzyme, BubR1, helps make sure chromosomes are equally distributed during mitosis might explain how the process of cell division goes so awry in cancer, according to researchers from Fox Chase Cancer Center.
The Substance Abuse and Mental Health Services Administration (SAMHSA) announced a new application process for its major block grant programs - the Substance Abuse Prevention and Treatment Block Grant and the Community Mental Health Services Block Grant. The change is designed to provide states greater flexibility to allocate resources for substance abuse and mental illness prevention, treatment and recovery services in their communities.
Agendia, Inc., a world leader in personalized medicine and molecular cancer diagnostics, announces the peer-reviewed publication of the primary outcome results of the Microarray In Node-negative and 1 to 3 positive lymph node Disease may Avoid ChemoTherapy (MINDACT) clinical trial in the prestigious New England Journal of Medicine (NEJM). (i, iii, iv) The publication demonstrates that 46% of breast cancer patients considered for chemotherapy, whose tumors are classified MammaPrint Low Risk, have excellent survival without chemotherapy, and can thus be candidates to avoid this toxic therapy.
› Verified 8 days ago
Dr. Linda M Crawford, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 7 Artisan Ln, Plymouth, NH 03264 Phone: 603-536-5665 | |
David S Fagan, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 101 Boulder Point Dr, Suite 1, Plymouth, NH 03264 Phone: 603-536-4000 Fax: 603-536-4001 | |
Dana A Merrithew, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 103 Boulder Point Drive, Plymouth, NH 03264 Phone: 603-536-1881 Fax: 603-238-2198 | |
Dr. John J Jehl, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 16 Hospital Road, Speare Hospitalist Program, Plymouth, NH 03264 Phone: 603-536-1120 Fax: 603-536-4828 | |
Alexandria Sarah Raifsnider, Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 19 Highland Ave, Plymouth, NH 03264 Phone: 603-393-1130 |